Protective role of 17β-estradiol and testosterone in apoptosis of skeletal muscle

Actualizaciones en Osteologia

Volumn 6, Issue 2, 2010, Pages 65-80

  Pronsato, L ^a   Ronda, A C ^a   Milanesi, L ^a   Vasconsuelo, A ^a   Boland, R ^a,b  

^a UNIVERSIDAD NACIONAL DEL SUR   (Argentina)

^b NONE   (Argentina)

Author keywords

Apoptosis; Estradiol; Sarcopenia; Skeletal muscle; Testosterone

Indexed keywords

CYTOCHROME C; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; HEAT SHOCK PROTEIN 27; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; SMALL INTERFERING RNA; TESTOSTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; CELL NUCLEUS; CELL PROTECTION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOSKELETON; GENE SILENCING; MITOCHONDRION; MOUSE; MUSCLE ATROPHY; NEWBORN; NONHUMAN; SKELETAL MUSCLE;

EID: 78049408447     PISSN: 16698975     EISSN: 16698983     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (50)

1. Dionne IJ, Kinaman KA, Poehlman ET. Sarcopenia and muscle function during menopause and horrmone-replacement therapy. J Nutr Health Aging 2000; 4:156-61.
2. Solomon AM, Bouloux PMG. Modifying muscle mass - the endocrine perspective. J Endocrinol 2006; 191: 349-60.
3. Kahlert S, Grohe C, Karas RH, Lobbert K, Neyses L, Vetter H. Effects of estrogen on skeletal myoblast growth. Biochem Biophys Res Commun 1997; 232:373-8. (Pubitemid 27216222)
4. Bhasin S, Calof OM, Storer TW et al. Drug insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging. Nat Clin Pract Endocrinol Metab 2006; 2:146-59.
5. Sinha-Hikim I, Artaza J, Woodhouse L, et al. Testosterone-induced increase in muscle size in healthy young men is with muscle fiber hypertrophy. Am J Physiol Endocrinol Metab 2002; 283: E154-64. (Pubitemid 34686681)
6. Sinha-Hikim I, Roth SM, Lee MI, Bhasin S. Testosterone induced muscle hypertrophy is associated with an increase in satellite cell number in healthy, young men. Am J Physiol Endocrinol Metab 2003; 285: E197-205.
7. Sinha-Hikim I, Cornford M, Gaytan H, Lee ML, Bhasin S. Effects of testosterone supplementation on skeletal muscle fiber hypertrophy and satellite cells in community dwelling, older men. J Clin Endocrinol Metab 2006; 91:3024-33. (Pubitemid 44271751)
8. Brown TJ, Khan T, Jones KJ. Androgen induced acceleration of functional recovery after rat siatic nerve injury. Restor Neurol Neurosci 1999; 15:289-95. (Pubitemid 30056184)
9. Boissonneault G. Evidence of apoptosis in the castration-induced atrophy of the rat levator ani muscle. Endocr Res 2001; 27:317-28. (Pubitemid 32952718)
10. Lemoine S, Granier P, Tiffoche C, Rannou-Bekono F, Thieulant ML, Delamarche P. Estrogen receptor alpha mRNA in human skeletal muscles. Med Sci Sports Exerc 2003; 35:439-43. (Pubitemid 36278769)
11. Wiik B, Glenmark M, Ekman M, et al. Oestrogen receptor beta is expressed in adult human skeletal muscle both at the mRNA and protein level. Acta Physiol Scand 2003; 179:381-7. (Pubitemid 38021588)
12. Bamman MM, Shipp JR, Jiang BA et al. Mechanical load increases muscle IGF-1 and androgen receptor mRNA concentrations in humans. Am J Physiol Endocrinol Metab 2001; 280:E383-90.
13. Doumit ME, Cook DR, Merkel RA. Testosterone up-regulates androgen receptors and decreases differentiation of porcine myogenic satellite cells in vitro. Endocrinology 1996; 137:1385-94.
14. Kadi F, Bonnerud P, Eriksson A, Thornell LE. The expression of androgen receptors in human neck and limb muscles: effects of training and self-administration of androgenic-anabolic steroids. Histochem Cell Biol 2000; 113:25-9. (Pubitemid 30164406)
15. Kadi F. Adaptation of human skeletal muscle to training and anabolic steroids. Acta Physiol Scand Suppl 2000; 646:1-52. (Pubitemid 30122220)
16. Carson JA, Lee WJ, McClung J, Hand GA. Steroid receptor concentration in aged rat hind limb muscle: effect of anabolic steroid administration. J Appl Physiol 2002; 93:242-50. (Pubitemid 34686218)
17. Vasconsuelo A, Milanesi LM, Boland RL. 17β-estradiol abrogates apoptosis in murine skeletal muscle cells through estrogen receptors: role of the phosphatidylinositol 3-kinase/Akt pathway. J Endocrinol 2008; 196:385-97. (Pubitemid 351298524)
18. Primeau AJ, Adhietty PJ, Hood DA. Apoptosis in heart and skeletal muscle. Can J Appl Physiol 2002; 27:349-95.
19. Dupont-Versteegden EE. Apoptosis in muscle atrophy: relevance to sarcopenia. Exp Gerentol 2005; 40:473-81.
20. Kujoth GC, Hiona A, Pugh TD, et al. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 2005; 309:481-4. (Pubitemid 40994689)
21. Tews DS. Muscle fiber apoptosis in neuromuscular diseases. Muscle Nerve 2005; 32:443-58.
22. Steller H. Mechanisms and genes of cellular suicide. Science 1995; 267:1445-9.
23. Kischkel FC, Hellbardt S, Behrmann I et al. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 1995; 14:5579-88.
24. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998; 281:1305-8.
25. Walsh K. Coordinate regulation of cell cycle and apoptosis during myogenesis. Prog Cell Cycle Res 1997; 3:53-8.
26. Sandri M, Carraro U. Apoptosis of skeletal muscles during development and disease. Int J Biochem Cell Biol 1999; 31:1373-90.
27. Huppertz B, Tews DS, Kaufmann P. Apoptosis and syncytial fusion in human placental trophoblast and skeletal muscle. Int Rev Cytol 2001; 205:215-53. (Pubitemid 32390831)
28. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002; 298:1911-2.
29. Wada T, Penninger JM. Mitogen-activated protein kinases in apoptosis regulation. Oncogene 2004; 23:2838-49. (Pubitemid 38638846)
30. Lin A, Dibling B. The true face of JNK activation in apoptosis. Aging Cell 2002; 1:112-6.
31. 2 and 4-hydroxynonenal mediate amyloid induced neuronal apoptosis by activation JNKs and p38 MAPK. Exp Neurol 2003; 180:144-55. (Pubitemid 36398169)
32. Caughlan A, Newhouse K, Namgung U, Xia Z. Chlorpyrifos induces apoptosis in rat cortical neurons that is regulated by a balance between p38 and ERK/JNK MAP kinases. Toxicol Sci 2004; 78:125-34. (Pubitemid 38351431)
33. Mehlen P, Schulze-Osthoff K, Arrigo AP. Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks Fas/APO-1- and staurosporine-induced cell death. J Biol Chem 1996; 271:16510-4.
34. Samali A, Cotter TG. Heat shock proteins increase resistance to apoptosis. Exp Cell Res 1996; 223:163-70. (Pubitemid 26063934)
35. Hartl F. Molecular chaperones in cellular protein folding. Nature 1996; 381:571-9.
36. Welch WJ. Mammalian stress response: cell physiology, structure/function of stress proteins, and implications for medicine and disease. Physiol Rev 1992; 72:1063-81.
37. Muchowski PJ, Bassuk JA, Lubsen NH, Clark JI. Human alphaB-crystallin. Small heat shock protein and molecular chaperone. J Biol Chem 1997; 272:2578-82.
38. Arrigo AP. Small stress proteins: chaperones that act as regulators of intracellular redox state and programmed cell death. Biol Chem 1998; 379:19-26
39. Arrigo AP, Landry J. Expression and function of the low-molecular-weight heat shock proteins. In: Morimoto RI, Tissieres A, Georgopoulos C (eds) The biology of heat shock proteins and molecular chaperones. Cold Spring Harbor Laboratory Press, New York, 1994, pp 335-73.
40. Bruey JM, Ducasse C, Bonniaud P et al. Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol 2000; 2:645-52.
41. Pandey P, Farber R, Nakazawa A. Hsp27 functions as a negative regulator of cytochrome c-dependent activation of procaspase-3. Oncogene 2000; 19:1975-81.
42. Mendelsohn ME, Zhu Y, O'Neill S. The 29-kDa proteins phosphorylated in thrombin-activated human platelets are forms of the estrogen receptor-related 27-kDa heat shock protein. PNAS 1991; 88:11212-6. (Pubitemid 21916010)
43. Ciocca DR, Oesterreich S, Chammess GC, McGuire WL, Fuqua SAW. Biological and clinical implications of heat shock protein 27000 (Hsp27): a review. J Natl Cancer Inst 1993; 85:1558-69.
44. Hansen RK, Parra I, Lemiux P, Oesterreich S, Hilsenbeck SG, Fuqua SAW. Hsp27 overexpression inhibits doxorubicin-induced apoptosis in human breast cancer cells. Breast Cancer Res Treta 1999; 56:187-96. (Pubitemid 29494836)
45. 2+ uptake in rat and chick cultured myoblasts. Biochim Biophys Acta 1996; 1310:157-62.
46. Milanesi L, De Boland AR, Boland R. Expression and localization of estrogen receptor α in the C2C12 murine skeletal muscle cell line. J Cell Biochem 2008; 104:1254-73. (Pubitemid 351961699)
47. Milanesi L, Vasconsuelo A, R. de Boland A, Boland R. Expression and subcellular distribution of native receptor beta in murine C2C12 cells and skeletal muscle tissue. Steroids 2009; 74:489-97.
48. Desagher S, Martinou JC. Mitochondria as the central control point of apoptosis. Trends Cell Biol 2000; 1:369-77. (Pubitemid 30612469)
49. Ernster L, Schatz G. Mitochondria: a historical review. J Cell Biol 1981; 91:227s-255s.
50. Miller H, Poon S, Hibbert B, Rayner K, Chen YX, O'Brien ER. Modulation of estrogen signaling by the novel interaction of HSP27, a biomarker for atherosclerosis, and estrogen receptor. Vasc Biol 2005; 25:10-4.